superior biocompatibility of Ioversol as a contrast agent, we demonstrate the in vivo use of this CEμCT technique to examine IVDs at multiple spinal sites. Ioversol was administered via tail vein injection (TVI) in growing and adult male FVB/NJ mice (n = 5 /group). The animals were anesthetized and underwent in vivo microcomputed tomographic (microCT) at the coccygeal (CC5/CC6), lumbar (L5/6), and thoracic (T12/T13) IVDs. TVI of Ioversol was well-tolerated by all animals. As Ioversol filtered through the kidneys and accumulated in the bladder, the attenuations of the mouse bladder and kidneys increased due to the high molecular weight of Ioversol, confirming that the Ioversol is biological available. Average IVD attenuations increased 3%-15% following TVI (ANOVA; P < .01). The presence of Ioversol in the IVD combined with high-resolution microCT allow for nondestructive visualization of structural features of the IVD. These results demonstrate CEμCT with Ioversol as a viable strategy for the in vivo monitoring of multiple mouse IVDs during degeneration, disease, and injury.
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| INTRODUCTION
Low back pain is one of the most common causes of disability. 1 With intervertebral disc (IVD) degeneration being a leading contributor to the development of low back pain, there is a need for a better understanding of the biological and structural changes of the IVD that occur with the disease and injury. 2 Mouse models are useful for studying the molecular mechanisms of IVD biology because of the number of genetically modified models and established techniques to induce degeneration. 3 However, resolving the micrometer-scale structural features of the mouse IVD remains a significant challenge even with state-of-the-art small animal microMRI technologies. 4 Micro-computed tomographic (microCT) techniques have outstanding spatial resolution for the volumetric imaging of mineralized tissues in rodents. 5 However, since nonmineralized tissues do not attenuate X-Rays, a contrast agent is required to differentiate the soft tissue of interest. Although ionic and heavy-metal and ionic contrastagents have shown to improve the X-ray attenuation of IVDs for ex vivo imaging 6, 7 , the nonionic, hydrophilic, and highly biocompatible nature of Ioversol make it particularly suited for in vivo use. 8 Ioversol has been used clinically as a diagnostic radiographic contrast agent. 
| MicroCT imaging
MicroCT imaging was conducted on a VivaCT40 system (Scanco Med- 
| Image processing
The raw data was exported to DICOM for further analysis using a cus- 
F I G U R E 2 A, TVI significantly increased the attenuations of the IVDs in the 3-and 8-month animals (3-way ANOVA; P < .01). B and C, The 3D data enables the unbiased quantification of disc height and whole disc volume. D, The whole disc attenuation ratio (DI/DI 0 ) increased in the adult lumbar IVDs mean attenuation of the post-TVI scan (DI) to the pre-TVI (DI 0 ) was calculated for both groups at all levels. Disc heights and visualizations were obtained using OsiriX (Pixmeo, Geneva, Switzerland). Disc height represents the average disc height across five evenly spaced points along the mid-sagittal plane of the IVD. The current CEμCT technique allows for the high-resolution imaging of the mouse IVD in vivo at spatial resolutions at tens of microns, 4 and thus can quantify the structural characteristics of the IVD with greater precision and fidelity. In addition, this approach allows for the imaging of multiple spinal sites with a single set up. TVI of Ioversol was well-tolerated by the mice and demonstrates the feasibility this technique for longitudinal studies. Previous studies have utilized in vivo microCT for longitudinal studies with no adverse events reported due to radiation. 13, 14 CEμCT will be a valuable strategy for in vivo monitoring of IVD injury and degeneration across multiple levels in mouse models.
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